
Also: What does the hemp supply landscape look like today?


Also: What does the hemp supply landscape look like today?

Rooted Apothecary is the seventh CBD company to receive an FDA warning letter in 2019.

The new ingredient is called Starmeric, and it offers a new use for this superstar herb, which until now has been best known for the health benefits of its active ingredient curcumin.

The guidelines, established in October, set forth a framework of best practices and compliance standards for hemp extract/cannabinoid products. They exclude synthetic CBD.

The Natural Products Association polled 1000 registered voters in early October.

DolCas Bioetech LLC is launching Bergacyn, a blend of botanical extracts from Italian bergamot citrus fruit (Citrus bergamia) and the wild-crafted Italian artichoke thistle leaf (Cynara cardunculus sylvestris).

Demand for joint-support supplements is perennially solid, but the changing face of the consumer is injecting new life into the category.

A recently published double-blind, randomized, placebo-controlled clinical study found that supplementation with KSM-66 ashwagandha root extract supports sleep quality and quantity.

Nutritional Outlook looks at a few standout natural ingredients for which sexual health research continues to evolve.

Arjuna Natural Pvt. Ltd. announced the results of a new study – currently under peer-review – that demonstrates the analgesic activity of its proprietary blend of three botanicals called Rhuleave-K.

The dietary supplement industry may see its share of critics and negative headlines, but there is also plenty of positive news. Take the recent numbers shared by leading associations indicating that more consumers than ever before are buying supplements of all kinds.

The study, expected to be published in November, shows that Turmacin significantly decreased measures of pain following exercise.

In a joint letter, the American Herbal Products Association, Consumer Healthcare Products Association, Council for Responsible Nutrition, and United Natural Products Alliance called on Congress “to pass legislation to clarify that CBD derived from the hemp plant is a lawful dietary ingredient.”

Jiaherb Inc. has partnered with the standards-setting organization USP to sponsor and validate a monograph for feverfew extract (Tanacetum parthenium L.), with plans to further support standards-setting activities for other botanicals.

AGEprost is an herbal extract of the plant Ageratum conyzoides, traditionally used in the Caribbean to support prostate health and urinary problems.

Infused waters, seltzers, sodas, and shots are just a few drinkable formats for hemp-derived CBD.

The American Herbal Products Association’s 8th Annual Botanical Congress will take place on Saturday, October 19, during SupplySide West 2019 in Las Vegas, NV.

The challenges of producing organic curcumin. And does organic really mean better?

Raw cannabis is distinctly different from both the cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD).

HerbalGram reports that sales increased by 9.4% in 2018 compared to the previous year. This is roughly a $757 million increase in sales and marks the strongest growth in herbal supplement sales since 1998.

Manufacturers and retailers must avoid making claims and instead focus on delivering high-quality products, one CEO writes.

A botanical education group weighs in on some of the dietary supplement industry’s notable adulteration concerns.

Senate Leader Mitch McConnell (R-KY) inserted “report language” into an appropriations bill being considered by the Senate Agriculture Appropriations Subcommittee that demands FDA take significant actions with respect to products containing cannabidiol (CBD).

BI has added a Hemp Soft Extract to its newly released line of full spectrum hemp ingredients, which will be showcased at SupplySide West 2019 in Las Vegas, NV.

The Natural Products Association reports that the U.S. Senate Agriculture Appropriations Committee failed to include legislation passed the House of Representatives that would have appropriated $100,000 for the FDA to perform a health hazard evaluation on CBD.